(Q33349202)

26 July 2017

title

Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial (English)

1 reference

26 July 2017

0 references

Gabriel Guízar-Sahagún

object named as

Gabriel Guízar-Sahagún

2

0 references

author name string

Israel Grijalva

1

1 reference

26 July 2017

Gilberto Castañeda-Hernández

3

1 reference

26 July 2017

Dolores Mino

4

1 reference

26 July 2017

Héctor Maldonado-Julián

5

1 reference

26 July 2017

Guadalupe Vidal-Cantú

6

1 reference

26 July 2017

Antonio Ibarra

7

1 reference

26 July 2017

Omar Serra

8

1 reference

26 July 2017

Hermelinda Salgado-Ceballos

9

1 reference

26 July 2017

Rita Arenas-Hernández

10

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

26 July 2017

1 reference

26 July 2017

volume

23

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

823-834

1 reference

Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Morphometric analysis of experimental spinal cord injury in the cat: the relation of injury intensity to survival of myelinated axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Spontaneous long-term remyelination after traumatic spinal cord injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Augmentation by 4-aminopyridine of vestibulospinal free fall responses in chronic spinal-injured cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

4-Aminopyridine enhances motor evoked potentials following graded spinal cord compression injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Neurophysiological evidence of spared upper motor conduction fibers in clinically complete spinal cord injury: discomplete SCI in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

SCIM--spinal cord independence measure: a new disability scale for patients with spinal cord lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Toward the operational identification of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

4-aminopyridine influences heart rate variability in long-standing spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Angina Pectoris and the Placebo Effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Axon sprouting in the spinal cord: growth promoting and growth inhibitory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Changing profiles in spinal cord injuries and risk factors influencing recovery after penetrating injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Clinical presentations, medical complications, and functional outcomes of individuals with gunshot wound-induced spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Modulation of astroglial cell proliferation by analogues of adenosine and ATP in primary cultures of rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

4-Aminopyridine in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Aminopyridines and the treatment of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Early rehabilitation effect for traumatic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

An additional basic science for clinical medicine: IV. The development of clinimetrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Relating axonal injury to functional recovery in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.823.32731

10.1592/PHCO.23.7.823.32731

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference